Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pratt

Showing results (631-640 of 752) with videos related to

Pageof 76
Sort By:
Diabetes|January 1, 2000
Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase CT M Osicka, Y Yu, S Panagiotopoulos, et al.
JACC. Heart Failure|April 29, 2017
Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the ENABLE TrialsMilton Packer, John J V McMurray, Henry Krum, et al.
Journal of Cardiovascular Electrophysiology|November 26, 1999
Evaluation of antiarrhythmic drug efficacy in patients with an ICD: unlimited potential or replete with complexity and problems?C M Pratt, A J Camm, J T Bigger, et al.
The American Journal of Cardiology|February 1, 1985
Intracoronary thrombolytic therapy in acute myocardial infarction: a prospective, randomized, controlled trialA E Raizner, F A Tortoledo, M S Verani, et al.
Proteomics|February 13, 2002
Stable isotope labelling in vivo as an aid to protein identification in peptide mass fingerprintingJulie M Pratt, Duncan H L Robertson, Simon J Gaskell, et al.
The American Journal of Cardiology|September 20, 2005
Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States (from the analysis of the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] database)Gilles E O'Hara, Lyne Charbonneau, Mary Chandler, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2002
Structure-activity relationships of the peptide deformylase inhibitor BB-3497: modification of the metal binding groupHelen K Smith, R Paul Beckett, John M Clements, et al.
Journal of the American College of Cardiology|December 19, 2006
A multinational study to establish the value of early adenosine technetium-99m sestamibi myocardial perfusion imaging in identifying a low-risk group for early hospital discharge after acute myocardial infarctionJohn J Mahmarian, Leslee J Shaw, Neil G Filipchuk, et al.
Journal of the American College of Cardiology|December 19, 2006
An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarctionJohn J Mahmarian, Habib A Dakik, Neil G Filipchuk, et al.
Pharmacogenetics and Genomics|November 30, 2018
Analytical validity of a genotyping assay for use with personalized antihypertensive and chronic kidney disease therapyKimberly S Collins, Victoria M Pratt, Wesley M Stansberry, et al.
Pageof 76

Showing results (631-640 of 752) with videos related to

Sort By:
Pageof 76
Diabetes|January 1, 2000
Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase CT M Osicka, Y Yu, S Panagiotopoulos, et al.
JACC. Heart Failure|April 29, 2017
Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the ENABLE TrialsMilton Packer, John J V McMurray, Henry Krum, et al.
Journal of Cardiovascular Electrophysiology|November 26, 1999
Evaluation of antiarrhythmic drug efficacy in patients with an ICD: unlimited potential or replete with complexity and problems?C M Pratt, A J Camm, J T Bigger, et al.
The American Journal of Cardiology|February 1, 1985
Intracoronary thrombolytic therapy in acute myocardial infarction: a prospective, randomized, controlled trialA E Raizner, F A Tortoledo, M S Verani, et al.
Proteomics|February 13, 2002
Stable isotope labelling in vivo as an aid to protein identification in peptide mass fingerprintingJulie M Pratt, Duncan H L Robertson, Simon J Gaskell, et al.
The American Journal of Cardiology|September 20, 2005
Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States (from the analysis of the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] database)Gilles E O'Hara, Lyne Charbonneau, Mary Chandler, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2002
Structure-activity relationships of the peptide deformylase inhibitor BB-3497: modification of the metal binding groupHelen K Smith, R Paul Beckett, John M Clements, et al.
Journal of the American College of Cardiology|December 19, 2006
A multinational study to establish the value of early adenosine technetium-99m sestamibi myocardial perfusion imaging in identifying a low-risk group for early hospital discharge after acute myocardial infarctionJohn J Mahmarian, Leslee J Shaw, Neil G Filipchuk, et al.
Journal of the American College of Cardiology|December 19, 2006
An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarctionJohn J Mahmarian, Habib A Dakik, Neil G Filipchuk, et al.
Pharmacogenetics and Genomics|November 30, 2018
Analytical validity of a genotyping assay for use with personalized antihypertensive and chronic kidney disease therapyKimberly S Collins, Victoria M Pratt, Wesley M Stansberry, et al.
Pageof 76